Lunai Bioworks
LNAI
21 hedge funds and large institutions have $6.65M invested in Lunai Bioworks in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 15 closing their positions.
680% more call options, than puts
Call options by funds: $351K | Put options by funds: $45K
490% more capital invested
Capital invested by funds: $1.13M → $6.65M (+$5.53M)
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
0.01% less ownership
Funds ownership: 0.04% → 0.03% (-0.01%)
30% less funds holding
Funds holding: 30 → 21 (-9)
60% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$280K |
| 2 |
Morgan Stanley
New York
|
+$166K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$84.2K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$62.6K |
| 5 |
BlackRock
New York
|
+$58.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HFRG
Houlihan Financial Resource Group
Ashburn,
Virginia
|
-$193K |
| 2 |
Millennium Management
New York
|
-$113K |
| 3 |
Goldman Sachs
New York
|
-$66.9K |
| 4 |
N
Natixis
Paris,
France
|
-$56.7K |
| 5 |
Jane Street
New York
|
-$47.1K |
LNAI Hedge Fund Activity: Q3 2023 in Review
21 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q3 2023, worth a combined $6.65M — up 490% from $1.13M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of LNAI and 6 opened new positions — a net loss of 9 holders — while 4 trimmed existing stakes and 7 added.
The largest buyer was Geode Capital Management, adding an estimated $280K. The largest seller was Houlihan Financial Resource Group, exiting entirely with an estimated $193K sold.
- 21 institutional investors held Lunai Bioworks (LNAI) as of Q3 2023, down from 30 in Q2 2023.
- Funds reported $6.65M of Lunai Bioworks stock for Q3 2023, up 490% quarter-over-quarter.
- 6 funds opened new Lunai Bioworks positions in Q3 2023 and 15 closed out, a net change of -9 holders.
- The largest Lunai Bioworks buyer in Q3 2023 was Geode Capital Management, an estimated $280K added.
- The largest Lunai Bioworks seller in Q3 2023 was Houlihan Financial Resource Group, an estimated $193K sold.
Based on aggregated 13F filings for Q3 2023.